Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases
Authors:
- Katrin LamszusKLKatrin Lamszus
- Sabine RiethdorfSRSabine Riethdorf
- Sönke Meyer-StaecklingSMSönke Meyer-Staeckling
- Markus GlatzelMarkus Glatzel
- Jakob MatschkeJakob Matschke
- Isabell WitzelIWIsabell Witzel
- Manfred WestphalMWManfred Westphal
- Burkhard BrandtBurkhard Brandt
- Volkmar MüllerVMVolkmar Müller
- Klaus PantelKPKlaus Pantel
- Harriet WikmanHarriet Wikman
- 1 July 2013
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 183 (1) , 83-95
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- New Target Therapies for Brain Metastases from Breast CancerCurrent Cancer Drug Targets, 2012
- Summary of Presentation from the Targeted Therapy in Lung Cancer MeetingJournal of Thoracic Oncology, 2011
- Receptor Tyrosine Kinases and Targeted Cancer TherapeuticsBiological and Pharmaceutical Bulletin, 2011
- The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biologyThe International Journal of Developmental Biology, 2011
- Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategiesEuropean Journal of Cancer, 2010
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- Detection, clinical relevance and specific biological properties of disseminating tumour cellsNature Reviews Cancer, 2008
- CNS Metastases in Breast CancerJournal of Clinical Oncology, 2004
- Brain metastasesCurrent Problems in Surgery, 2004
- Determinants and prognoses of locoregional and distant progression in breast cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003